Sign In   Register
Loading cover... Drag cover to reposition
Lexaria Bioscience Corp.

Lexaria Bioscience Corp.

  Private Company
Timeline
About
Audio
Blog
Events
Pages
Videos
More    
← Back To Videos
Done
x
Play video and select frame to capture or upload thumbnail
  Play   Capture Upload Own Image

Lexaria Bio Science files patent for technology to treat infection disease including Corona

By Lexaria Bioscience Corp. in News 1st Oct, 2020 Video Duration: 00:05:21
Lexaria Bioscience (CSE: LXX-OTC: LXRP) CEO Chris Bunka joined Steve Darling from Proactive Vancouver to discuss the company has filed a patent for their DehydraTech technology for the delivery of antiviral drugs.

Bunka telling Proactive this technology would potentially be used to improve treatment options for viral infectious diseases including COVID-19, MERS, SARS, influenza, herpes, hepatitis and AIDS.
People In This Video
No users are tagged in this video
Previous
Lexaria receives ethics board ok to launch human study with DehydraTech for delivering antivirals
0
0
0
0
0
0
Comments (0)

Other Videos

00:02:21
Marijuana enthusiasts celebrate weed's strides on 4/20
  1. Pitch
  2. •
  3. 25th Apr, 2024
  1. MjInvest Events
  • 0
  • 0
00:05:31
Road to Full Cannabis Legalization in the U.S.
  1. Pitch
  2. •
  3. 24th Apr, 2024
  1. MjInvest Events
  • 0
  • 0
00:05:44
Former Wrestler-Turned-Governor Jesse Ventura's New Cannabis Business
  1. Pitch
  2. •
  3. 23rd Apr, 2024
  1. MjInvest Events
  • 0
  • 0
00:02:32
Decline in demand for marijuana leads to tough decision for business in Colorado's high country
  1. Pitch
  2. •
  3. 22nd Apr, 2024
  1. MjInvest Events
  • 0
  • 0
00:02:05
Minnesota state House passes new Marijuana proposal
  1. Pitch
  2. •
  3. 22nd Apr, 2024
  1. MjInvest Events
  • 0
  • 0
00:11:28
Recreational Marijuana in Florida | Facing South Florida
  1. Pitch
  2. •
  3. 19th Apr, 2024
  1. MjInvest Events
  • 0
  • 0
Unable to load tooltip content.

Copyright 2019 - 2024. MjInvest.com and MjMicro Cap are divisions of MjLink.com, Inc.. All rights reserved. MjInvest

Legal Disclaimer - https://www.mjinvest.com/legal-disclaimer

To contact the following departments, dial 1-844-420-4208 - Sales: Ext. #2 - Support: Ext. #3 - Investor Relations: Ext. #6

By using this website, you agree and understand that, by law:
You MUST be at least 21 years of age to view any content on this website. To view the complete Terms of Use and Privacy Policy for this website, Click Here!


MjInvest.com